E. Samantas

2.6k total citations
68 papers, 1.9k citations indexed

About

E. Samantas is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, E. Samantas has authored 68 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Oncology, 27 papers in Pulmonary and Respiratory Medicine and 14 papers in Epidemiology. Recurrent topics in E. Samantas's work include Lung Cancer Treatments and Mutations (18 papers), Lung Cancer Research Studies (17 papers) and Cancer Treatment and Pharmacology (14 papers). E. Samantas is often cited by papers focused on Lung Cancer Treatments and Mutations (18 papers), Lung Cancer Research Studies (17 papers) and Cancer Treatment and Pharmacology (14 papers). E. Samantas collaborates with scholars based in Greece, Germany and United States. E. Samantas's co-authors include George Fountzilas, Dimosthenis Skarlos, P. Kosmidis, Nicholas Pavlidis, Haralabos P. Kalofonos, Dimitrios Bafaloukos, Dimitrios Pectasides, Pavlos Papakostas, Evangelos Briasoulis and Christos Christodoulou and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Annals of Oncology.

In The Last Decade

E. Samantas

65 papers receiving 1.9k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
E. Samantas 1.5k 618 542 491 233 68 1.9k
Anna M. Varghese 1.8k 1.2× 1.0k 1.6× 289 0.5× 689 1.4× 307 1.3× 111 2.6k
Virginia Ferraresi 1.3k 0.8× 1.0k 1.7× 96 0.2× 635 1.3× 162 0.7× 125 2.4k
Caroline S. Verbeke 1.7k 1.1× 554 0.9× 406 0.7× 462 0.9× 165 0.7× 46 2.3k
Hussein Tawbi 1.1k 0.7× 694 1.1× 112 0.2× 739 1.5× 177 0.8× 108 2.0k
D Moro 1.1k 0.7× 668 1.1× 314 0.6× 693 1.4× 243 1.0× 44 1.8k
Jesse S. Voss 852 0.6× 700 1.1× 223 0.4× 395 0.8× 328 1.4× 70 2.0k
Makoto Kodaira 855 0.6× 643 1.0× 159 0.3× 627 1.3× 234 1.0× 70 2.0k
Jin Hyoung Kang 1.7k 1.1× 1.9k 3.0× 128 0.2× 1.0k 2.0× 188 0.8× 116 3.1k
Katja Lindel 708 0.5× 466 0.8× 358 0.7× 322 0.7× 129 0.6× 60 1.9k
Mehmet Altan 2.1k 1.3× 885 1.4× 376 0.7× 364 0.7× 96 0.4× 121 2.5k

Countries citing papers authored by E. Samantas

Since Specialization
Citations

This map shows the geographic impact of E. Samantas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Samantas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Samantas more than expected).

Fields of papers citing papers by E. Samantas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Samantas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Samantas. The network helps show where E. Samantas may publish in the future.

Co-authorship network of co-authors of E. Samantas

This figure shows the co-authorship network connecting the top 25 collaborators of E. Samantas. A scholar is included among the top collaborators of E. Samantas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Samantas. E. Samantas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Αγιαννιτόπουλος, Κωνσταντίνος, Georgios Tsaousis, Mustafa Özdoğan, et al.. (2023). Genetic testing in patients with pancreatic cancer to reveal pathogenic variants in cancer susceptibility genes.. Journal of Clinical Oncology. 41(16_suppl). e16276–e16276. 1 indexed citations
3.
Linardou, Helena, G. Kouvatseas, Giannis Mountzios, et al.. (2019). Genotyping KRAS and EGFR Mutations in Greek Patients With Non-small-cell Lung Cancer: Incidence, Significance and Implications for Treatment. Cancer Genomics & Proteomics. 16(6). 531–541. 11 indexed citations
4.
Sgouros, Joseph, et al.. (2017). Effective use of levosimendan in anthracycline-induced cardiomyopathy: A case report. Heart & Lung. 46(5). 382–386. 4 indexed citations
5.
Sgouros, Joseph, et al.. (2017). Posterior Reversible Encephalopathy Syndrome During Treatment with Aflibercept, 5-Fluorouracil, Leucovorin, and Irinotecan for Metastatic Colorectal Cancer. Journal of Gastrointestinal Cancer. 50(1). 123–126. 2 indexed citations
6.
Linardou, Helena, Konstantine T. Kalogeras, Ralf Kronenwett, et al.. (2015). Prognostic Significance of VEGFC and VEGFR1 mRNA Expression According to HER2 Status in Breast Cancer: A Study of Primary Tumors from Patients with High-risk Early Breast Cancer Participating in a Randomized Hellenic Cooperative Oncology Group Trial.. PubMed. 35(7). 4023–36. 6 indexed citations
9.
Pliarchopoulou, Kyriaki, Konstantine T. Kalogeras, Ralf Kronenwett, et al.. (2012). Prognostic significance of RACGAP1 mRNA expression in high-risk early breast cancer: a study in primary tumors of breast cancer patients participating in a randomized Hellenic Cooperative Oncology Group trial. Cancer Chemotherapy and Pharmacology. 71(1). 245–255. 47 indexed citations
10.
Kosmidis, P., George Fountzilas, Anastasia G Eleftheraki, et al.. (2010). Paclitaxel and gemcitabine versus paclitaxel and vinorelbine in patients with advanced non-small-cell lung cancer. A phase III study of the Hellenic Cooperative Oncology Group (HeCOG). Annals of Oncology. 22(4). 827–834. 12 indexed citations
11.
Fountzilas, George, Mattheos Bobos, Anna Kalogera‐Fountzila, et al.. (2008). Gemcitabine Combined with Gefitinib in Patients with Inoperable or Metastatic Pancreatic Cancer: A Phase II Study of the Hellenic Cooperative Oncology Group with Biomarker Evaluation. Cancer Investigation. 26(8). 784–793. 54 indexed citations
12.
Kalofonos, Haralabos P., Aristotelis Bamias, Αngelos Koutras, et al.. (2008). A randomised phase III trial of adjuvant radio-chemotherapy comparing Irinotecan, 5FU and Leucovorin to 5FU and Leucovorin in patients with rectal cancer: A Hellenic Cooperative Oncology Group Study. European Journal of Cancer. 44(12). 1693–1700. 12 indexed citations
13.
Karanikiotis, Charisios, Theofanis Economopoulos, Samuel Murray, et al.. (2008). HLA Class II Alleles and the Presence of Circulating Epstein-Barr Virus DNA in Greek Patients with Nasopharyngeal Carcinoma. Strahlentherapie und Onkologie. 184(6). 325–331. 8 indexed citations
14.
Briasoulis, Evangelos, George Fountzilas, Aristotelis Bamias, et al.. (2007). Multicenter phase-II trial of irinotecan plus oxaliplatin [IROX regimen] in patients with poor-prognosis cancer of unknown primary: a hellenic cooperative oncology group study. Cancer Chemotherapy and Pharmacology. 62(2). 277–284. 20 indexed citations
15.
Mauri, Davide, George Pentheroudakis, D. Bafaloukos, et al.. (2006). Non-small cell lung cancer in the young: a retrospective analysis of diagnosis, management and outcome data.. PubMed. 26(4B). 3175–81. 43 indexed citations
16.
Pentheroudakis, George, et al.. (2005). Chemotherapy for patients with two favourable subsets of unknown primary carcinoma: Active, but how effective?. Acta Oncologica. 44(2). 155–160. 24 indexed citations
18.
Pentheroudakis, George, George Fountzilas, Dimitrios Bafaloukos, et al.. (2005). Metastatic breast cancer with liver metastases: a registry analysis of clinicopathologic, management and outcome characteristics of 500 women. Breast Cancer Research and Treatment. 97(3). 237–244. 90 indexed citations
19.
Fountzilas, George, George P. Stathopoulos, George Kouvatseas, et al.. (2004). Adjuvant Cytotoxic and Endocrine Therapy in Pre- and Postmenopausal Patients With Breast Cancer and One to Nine Infiltrated Nodes. American Journal of Clinical Oncology. 27(1). 57–67. 1 indexed citations
20.
Briasoulis, Evangelos, Maria Tsokos, George Fountzilas, et al.. (1998). Bcl2 and p53 protein expression in metastatic carcinoma of unknown primary origin: biological and clinical implications. A Hellenic Co-operative Oncology Group study.. PubMed. 18(3B). 1907–14. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026